TENAX THERAPEUTICS INC
TENXNASDAQ🏆 #4464 by market capEarnings Nov 10US Equity
$1.84▼ $0.01 (−0.54%)
Market closed · at closeTrack TENX
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d▼ 3.7%
14d▲ 1.1%
30d▲ 0.0%
ytd▼ 84.9%
1y▼ 75.9%
🏦Market Cap
$49M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
56
Weak
TENAX THERAPEUTICS INC
TENXAnalyst Ratings
Price
$1.84
Total
9
Raised
1
Lowered
4
Avg PT
$4.40
H / L
$5 / $4
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Guggenheim | Downgraded | Buy → Neutral | 2026-08-31 | $4.00 | +117.40% |
Chardan Capital | Downgraded | Buy → Neutral | 2026-08-11 | $5.00 | +171.70% |
Canaccord Genuity | Reiterated | Buy | 2026-08-11 | $4.00 | +117.40% |
Evercore ISI Group | Downgraded | Outperform → In Line | 2026-08-11 | — | — |
William Blair | Downgraded | Outperform → Market Perform | 2026-08-10 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-29 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-06-12 | $20.00 | +987.00% |
Roth MKM | Reiterated | Buy | 2024-02-20 | — | — |
Ladenburg Thalmann | Upgraded | Neutral → Buy | 2017-05-18 | — | — |
Institution
Guggenheim
Downgraded · Buy → Neutral · 2026-08-31
$4.00
+117.40%
Chardan Capital
Downgraded · Buy → Neutral · 2026-08-11
$5.00
+171.70%
Canaccord Genuity
Reiterated · Buy · 2026-08-11
$4.00
+117.40%
Evercore ISI Group
Downgraded · Outperform → In Line · 2026-08-11
—
—
William Blair
Downgraded · Outperform → Market Perform · 2026-08-10
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-07-29
—
—
Piper Sandler
Reiterated · Overweight · 2026-06-12
$20.00
+987.00%
Roth MKM
Reiterated · Buy · 2024-02-20
—
—
Ladenburg Thalmann
Upgraded · Neutral → Buy · 2017-05-18
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space